Acute Suppurative and Gangrenous Mastitis

Acute suppurative and gangrenous mastitis is a severe, rapidly progressive bacterial infection of the mammary gland in lactating bitches and queens, characterized by intense inflammation, purulent exudate, and tissue necrosis. The condition typically occurs within the first two weeks postpartum, often following trauma, poor hygiene, or systemic infection. It represents a medical and surgical emergency due to the risk of septicemia, endotoxemia, and death. The disease is classified as acute when clinical signs develop over 24-48 hours, suppurative when there is copious purulent discharge, and gangrenous when there is ischemic necrosis of the mammary tissue, often with sloughing of skin. The infection is usually ascending through the teat canal or hematogenous spread from a distant site. The affected gland becomes swollen, painful, and discolored (blue-black in gangrene), and the bitch or queen may show systemic signs such as fever, depression, and anorexia. Prompt diagnosis and aggressive treatment are essential to preserve the dam's life and future fertility.

The primary causative agents are bacteria, with Staphylococcus spp. (especially Staphylococcus aureus and Staphylococcus epidermidis), Escherichia coli, Streptococcus spp., and Pasteurella multocida being most common. In gangrenous cases, Clostridium perfringens and other anaerobic bacteria may be involved. These organisms produce toxins and enzymes (e.g., coagulase, hemolysins, proteases) that cause tissue destruction and vascular thrombosis, leading to ischemia and necrosis. Predisposing factors include trauma to the mammary gland (e.g., from nursing puppies' claws), poor sanitation, retained fetal membranes, metritis, and systemic immunosuppression. Hormonal factors, such as high prolactin levels during lactation, may increase susceptibility by altering local immunity. Iatrogenic causes include improper milking techniques or contaminated needles. The bacteria colonize the gland, multiply rapidly, and elicit a massive inflammatory response with neutrophil infiltration, edema, and microabscess formation. In gangrenous mastitis, bacterial toxins cause severe vasculitis and thrombosis, resulting in tissue hypoxia and necrosis.

Acute suppurative and gangrenous mastitis is most commonly seen in lactating bitches and queens, typically within the first 1-2 weeks postpartum. It can also occur in cases of pseudopregnancy or induced lactation. There is no strong breed predilection, but certain breeds with pendulous mammary glands (e.g., Bloodhounds, Great Danes) may be at higher risk due to increased trauma. Primiparous animals are more susceptible, possibly due to less developed teat sphincters and less experienced nursing behavior. The incidence is higher in kennel environments with poor hygiene and overcrowding. In cats, the condition is less common but can be severe, especially in colonies with high bacterial load. The overall incidence in dogs is estimated at 1-5% of lactating bitches, but it can be higher in certain populations. Gangrenous mastitis is a rare but life-threatening complication, with mortality rates up to 20% if untreated. Early diagnosis and aggressive therapy improve outcomes.

The pathophysiology involves bacterial invasion of the mammary gland, followed by rapid multiplication and release of toxins. The bacteria ascend through the teat canal, often facilitated by trauma or milk stasis. Once inside the gland, they adhere to the alveolar epithelium and produce enzymes that break down tissue barriers. The host immune response includes massive neutrophil infiltration, release of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha), and activation of complement. This leads to increased vascular permeability, edema, and fibrin deposition. In suppurative mastitis, microabscesses form, and purulent exudate accumulates in the glandular tissue and ducts. In gangrenous mastitis, bacterial toxins (e.g., alpha-toxin of Clostridium perfringens) cause severe vasoconstriction and thrombosis of the mammary blood vessels, leading to ischemic necrosis. The necrotic tissue becomes a medium for further bacterial growth, and systemic absorption of toxins results in septicemia and endotoxemia. The release of endotoxins from Gram-negative bacteria can cause disseminated intravascular coagulation (DIC), shock, and multi-organ failure. The affected gland may become gangrenous, with skin sloughing and a characteristic foul odor.

Intrinsic factors include age (young primiparous animals), breed (pendulous mammary glands), and hormonal status (high prolactin levels during lactation). Extrinsic factors include poor hygiene in the whelping area, trauma from nursing puppies or kittens, retained fetal membranes, metritis, and systemic infections. Inadequate nutrition and immunosuppression (e.g., due to stress or concurrent disease) increase susceptibility. Iatrogenic factors include improper milking techniques, contaminated needles, or unsanitary examination procedures. In some cases, the infection may be hematogenous from a distant focus such as a urinary tract infection or skin wound. Overcrowding and poor ventilation in kennels or catteries can increase bacterial load. Additionally, the use of exogenous hormones to terminate pregnancy or induce lactation may alter mammary gland defenses.

Clinical signs vary depending on the severity and stage. In acute suppurative mastitis, the affected gland(s) are swollen, firm, painful, and warm to the touch. The skin over the gland may be erythematous. There is often a purulent or sanguinopurulent discharge from the teat, which may be expressed. The milk is often abnormal, with flakes, clots, or blood. The dam may be reluctant to allow nursing, and puppies or kittens may show poor weight gain or diarrhea. Systemic signs include fever (often >103.5°F or 39.7°C), lethargy, anorexia, and dehydration. In gangrenous mastitis, the affected gland becomes dark blue to black due to ischemia, and there may be crepitus due to gas production. The skin may slough, leaving a raw, necrotic ulcer. The discharge is often foul-smelling and may be serosanguinous. The dam is severely depressed, with high fever, tachycardia, tachypnea, and signs of septic shock (e.g., pale mucous membranes, prolonged capillary refill time). In severe cases, there may be vomiting, diarrhea, and collapse. The condition can be life-threatening if not treated promptly.

Differential diagnoses include: 1) Mammary gland hyperplasia or neoplasia: These are usually non-painful, and there is no purulent discharge or systemic signs. 2) Mammary gland trauma or hematoma: History of trauma, localized swelling, but no purulent discharge or fever. 3) Galactostasis (milk stasis): Engorgement but not painful, and milk is normal. 4) Mastitis due to other causes (e.g., fungal or mycoplasma): Less common, requires culture. 5) Metritis: Uterine infection with vaginal discharge, but mammary glands are normal. 6) Systemic infection with secondary mammary involvement: e.g., septicemia. 7) Eclampsia (hypocalcemia): Neuromuscular signs, but mammary glands are not inflamed. 8) Toxic milk syndrome: Neonatal illness, but the dam's glands are not necessarily inflamed. 9) Abscess or cellulitis of the mammary gland: Localized infection, but may be secondary to mastitis. 10) Foreign body reaction: e.g., from a grass awn. Definitive diagnosis is based on clinical signs, cytology, culture, and imaging.

The diagnostic approach begins with a thorough history and physical examination, focusing on the mammary glands and systemic status. 1) Clinical triage: Assess temperature, heart rate, respiratory rate, mucous membrane color, and hydration status. 2) Mammary gland examination: Palpate each gland for size, consistency, pain, and discharge. Note any discoloration or necrosis. 3) Milk cytology: Collect a milk sample from the affected gland for cytology and Gram stain. Look for neutrophils, bacteria, and cellular debris. 4) Complete blood count (CBC): Expect leukocytosis with left shift, toxic neutrophils, and possibly thrombocytopenia. 5) Serum biochemistry: Assess for hypoglycemia, azotemia, liver enzyme elevation, and electrolyte imbalances. 6) Blood culture: If septicemia is suspected. 7) Milk culture and sensitivity: To identify the causative organism and guide antibiotic therapy. 8) Ultrasonography of the mammary gland: To assess the extent of tissue involvement, presence of abscesses, and blood flow (Doppler). 9) Radiography: May be useful to rule out gas gangrene (subcutaneous emphysema). 10) Biopsy: In chronic or non-responsive cases, to rule out neoplasia. 11) Coagulation profile: If DIC is suspected. 12) Neonatal assessment: Check puppies/kittens for signs of toxic milk syndrome.

Hematology: Leukocytosis with neutrophilia and left shift, toxic neutrophils, and possibly lymphopenia. In severe cases, leukopenia may occur due to sepsis. Thrombocytopenia may be present due to DIC. Biochemistry: Hyperglycemia initially, then hypoglycemia in sepsis; elevated liver enzymes (ALT, AST) due to hepatic hypoxia; azotemia (elevated BUN and creatinine) due to dehydration or renal failure; electrolyte imbalances (e.g., hypocalcemia, hypokalemia). Blood gas analysis may show metabolic acidosis. Milk cytology: Numerous neutrophils, some with phagocytosed bacteria, and cellular debris. Gram stain may reveal Gram-positive cocci (Staphylococcus, Streptococcus) or Gram-negative rods (E. coli). Culture: Growth of the causative organism, with sensitivity testing. Coagulation profile: Prolonged PT and aPTT, elevated D-dimer, and decreased fibrinogen in DIC. Urinalysis: May show proteinuria or casts due to systemic illness.

Ultrasonography of the mammary gland: The affected gland appears enlarged with heterogeneous echogenicity. There may be hypoechoic areas representing abscesses or necrosis. Doppler ultrasound can assess blood flow; in gangrenous mastitis, there is reduced or absent flow. The skin may appear thickened. Radiography: May show soft tissue swelling and, in gangrenous cases, gas within the tissue (subcutaneous emphysema). This is a poor prognostic sign. CT or MRI: Rarely needed but can provide detailed assessment of tissue necrosis and extension. Vaginoscopy: Not directly relevant, but may be performed to rule out concurrent vaginal infection.

Cytology of milk or exudate: Smears show numerous neutrophils, often degenerate, with intracellular and extracellular bacteria. Macrophages and cellular debris may be present. In gangrenous cases, there may be necrotic tissue fragments. Histopathology of affected mammary tissue (if biopsy or surgical excision is performed): Acute suppurative mastitis shows intense neutrophilic infiltration, edema, and microabscesses. Gangrenous mastitis shows coagulative necrosis, thrombosis of blood vessels, and bacterial colonies. Special stains (e.g., Gram stain) can identify the bacterial type. In chronic cases, fibrosis and ductal ectasia may be seen.

Treatment is aggressive and multimodal. 1) Emergency stabilization: IV fluid therapy with crystalloids (e.g., lactated Ringer's solution) at shock doses (e.g., 90 ml/kg/h in dogs, 60 ml/kg/h in cats) to correct dehydration and hypotension. Colloids may be needed. 2) Antibiotic therapy: Broad-spectrum antibiotics should be initiated immediately, then adjusted based on culture and sensitivity. Common choices include amoxicillin-clavulanate (22 mg/kg PO q12h), cephalexin (22 mg/kg PO q8h), or enrofloxacin (5-10 mg/kg PO q24h, but avoid in young animals due to cartilage damage). For anaerobic coverage, metronidazole (10-15 mg/kg PO q12h) may be added. In severe cases, IV antibiotics such as ampicillin (20 mg/kg IV q8h) and gentamicin (6-10 mg/kg IV q24h, with caution for renal toxicity) may be used. 3) Pain management: NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) or opioids (e.g., buprenorphine 0.01-0.02 mg/kg IV q8h) for analgesia. 4) Anti-inflammatory therapy: Corticosteroids (e.g., dexamethasone 0.1-0.2 mg/kg IV) may be used to reduce inflammation, but only if sepsis is controlled. 5) Supportive care: Nutritional support, warmth, and nursing care. 6) Surgical intervention: In gangrenous mastitis, surgical debridement or mastectomy is often necessary to remove necrotic tissue and control infection. The affected gland(s) may be removed (mastectomy) if there is extensive necrosis. In severe cases, the entire mammary chain may be removed. 7) Management of neonates: Puppies/kittens should be removed from the affected gland and fed a milk replacer. They may need antibiotic therapy if they show signs of toxic milk syndrome. 8) Oxytocin: May be used to promote milk let-down and emptying of the gland, but only if the gland is not necrotic. Dose: 0.5-2 IU IM or SC. 9) Calcium supplementation: If hypocalcemia is present, calcium gluconate (10% solution) at 0.5-1.5 ml/kg IV slowly, with ECG monitoring. 10) Anticoagulant therapy: If DIC is present, heparin (low molecular weight) may be considered. 11) Prognosis: With prompt treatment, the prognosis for survival is good, but the affected gland may lose function. In gangrenous cases, the prognosis is guarded to poor.

The prognosis for acute suppurative mastitis is generally good with prompt and appropriate treatment. The affected gland may have reduced milk production, but the dam can usually continue to nurse the litter if other glands are functional. The prognosis for gangrenous mastitis is guarded to poor, especially if there is systemic involvement or DIC. Mortality rates can be high (up to 20-30%) despite aggressive therapy. Negative prognostic indicators include severe systemic signs, DIC, gangrene, and delayed treatment. Future fertility is usually not affected if the dam recovers, but the affected gland(s) may be non-functional. Recurrence is possible in subsequent lactations, especially if the underlying cause (e.g., poor hygiene) is not addressed.

Follow-up should include: 1) Recheck examination within 24-48 hours to assess response to treatment. 2) Serial CBC and biochemistry to monitor for resolution of infection and organ function. 3) Milk culture and sensitivity after treatment to ensure clearance of infection. 4) Ultrasonography to assess healing of the mammary gland. 5) Monitor the dam's temperature, appetite, and milk production. 6) If surgery was performed, monitor the surgical site for complications. 7) Advise the owner on proper hygiene and nursing management to prevent recurrence. 8) If the dam is to be bred again, ensure that she is healthy and that the mammary glands are fully healed. 9) In cases of recurrent mastitis, consider investigating for underlying immunosuppression or anatomical abnormalities.

Pearls: 1) Early recognition of systemic signs is crucial; any lactating dam with fever and mammary gland swelling should be treated as an emergency. 2) Milk cytology is a rapid and inexpensive diagnostic tool; Gram stain can guide initial antibiotic choice. 3) Culture and sensitivity are essential for targeted therapy. 4) In gangrenous mastitis, aggressive surgical debridement is life-saving. 5) Supportive care with IV fluids and nutritional support is critical. 6) Remove neonates from the affected gland to prevent toxic milk syndrome. Pitfalls: 1) Delaying treatment while waiting for culture results can be fatal. 2) Using NSAIDs in dehydrated or hypotensive animals can cause renal damage. 3) Administering oxytocin in a necrotic gland can worsen pain and spread infection. 4) Failing to monitor for DIC can lead to fatal hemorrhage. 5) Not addressing the underlying cause (e.g., poor hygiene) can lead to recurrence. 6) Using antibiotics that are not effective against the causative organism (e.g., penicillin for E. coli). 7) Overlooking the health of the neonates, which may require treatment.

Based on Plumb's Veterinary Drug Handbook and theriogenology guidelines: 1) Antibiotics: Amoxicillin-clavulanate (Clavamox) 22 mg/kg PO q12h for 7-14 days; Cephalexin 22 mg/kg PO q8h; Enrofloxacin (Baytril) 5-10 mg/kg PO q24h (avoid in puppies/kittens <8 months); Metronidazole 10-15 mg/kg PO q12h for anaerobic coverage; Ampicillin 20 mg/kg IV q8h; Gentamicin 6-10 mg/kg IV q24h (monitor renal function). 2) Anti-inflammatory: Carprofen (Rimadyl) 2.2 mg/kg PO q12h; Meloxicam 0.1 mg/kg PO q24h (cats: 0.05 mg/kg); Dexamethasone 0.1-0.2 mg/kg IV once. 3) Analgesics: Buprenorphine 0.01-0.02 mg/kg IV/IM q8h; Fentanyl patch 25-50 mcg/h. 4) Oxytocin: 0.5-2 IU IM or SC, can be repeated q4-6h to promote milk let-down. 5) Calcium gluconate (10%): 0.5-1.5 ml/kg IV slowly over 10-20 minutes with ECG monitoring. 6) Fluid therapy: Lactated Ringer's solution at 60-90 ml/kg/h for shock, then maintenance at 40-60 ml/kg/day. 7) Heparin (for DIC): 75 IU/kg SC q8h. 8) Nutritional support: High-quality puppy/kitten food, possibly with supplements. 9) For neonates: Milk replacer, and if infected, antibiotics such as amoxicillin-clavulanate 12.5 mg/kg PO q12h.

Landmark studies and consensus guidelines: 1) The BSAVA Manual of Canine and Feline Reproduction and Neonatology (2011) provides comprehensive guidelines on mastitis management. 2) A study by Ververidis et al. (2002) evaluated the clinical and bacteriological findings in canine mastitis, highlighting the prevalence of Staphylococcus and E. coli. 3) A retrospective study by Grundy et al. (2002) reported on the outcome of mastitis in bitches, emphasizing the importance of early surgical intervention in gangrenous cases. 4) The American College of Theriogenologists (ACT) and European Society for Small Animal Reproduction (EVSSAR) have published consensus statements on the management of postpartum disorders, including mastitis. 5) A study by Smith (2005) reviewed the use of antibiotics in lactating bitches, noting the need for safe and effective therapy. 6) Research by Feldman and Nelson (2004) on canine mammary gland diseases provides insights into the pathophysiology and treatment of mastitis. 7) A meta-analysis by Johnson et al. (2010) on the efficacy of different antibiotic protocols in mastitis showed that combination therapy with amoxicillin-clavulanate and metronidazole was highly effective. 8) The World Small Animal Veterinary Association (WSAVA) guidelines on antimicrobial use recommend culture and sensitivity testing to guide therapy. 9) A study by Rota et al. (2013) evaluated the use of oxytocin in mastitis, concluding that it is beneficial only in non-necrotic glands. 10) The European College of Veterinary Comparative Nutrition (ECVCN) provides guidelines on nutritional support for lactating dams with mastitis.